| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/07/2005 | WO2005030724A1 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders |
| 04/07/2005 | WO2005030678A2 AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS |
| 04/07/2005 | WO2005030212A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 04/07/2005 | WO2005030140A2 C-met modulators and methods of use |
| 04/07/2005 | WO2005030129A2 Quinoline potassium channel inhibitors |
| 04/07/2005 | WO2005012260A3 Synthetic method for the preparation of quinazolin-4-one derivative |
| 04/07/2005 | WO2005007094A3 Asthma and allergic inflammation modulators |
| 04/07/2005 | WO2004101530A8 A method for producing diverse set of dithioate compounds |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075502 Cellulose tris (4-chlorophenyl carbamate) on stationary phase in liquid chhromatograhy column separates optical isomers |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one |
| 04/07/2005 | US20050074796 Comprises benzazolium, pyridinium, or quinolinium connected by methine bridge; reporter molecules for detection of RNA in presence of DNA; solid phase synthesis; kits |
| 04/07/2005 | US20050074631 Luminescent efficiency and a long luminescent life |
| 04/07/2005 | DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/07/2005 | CA2744997A1 C-met modulators and method of use |
| 04/07/2005 | CA2540021A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | CA2538037A1 Amino-substituted ethylamino .beta.2 adrenergic receptor agonists |
| 04/07/2005 | CA2537812A1 C-met modulators and method of use |
| 04/06/2005 | EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1603311A Process for preparing quinolone pharmaceutical intermediates |
| 04/06/2005 | CN1195816C Electroluminescent quinolates |
| 04/06/2005 | CN1195752C Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same |
| 04/06/2005 | CN1195740C Pharmaceutical compositions comprising 2-quinolones |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875869 Process for the manufacture of quinoline derivatives |
| 04/05/2005 | US6875769 Substituted6,6-hetero-bicyclicderivatives |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875764 Urea and thiourea compounds useful for treatment of coccidiosis |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 03/31/2005 | WO2005028471A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 03/31/2005 | WO2005028443A2 Protein tyrosine kinase enzyme inhibitors |
| 03/31/2005 | WO2005028439A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | WO2005028421A2 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile |
| 03/31/2005 | WO2004103973A8 Phenyl quinolines and their use as estrogen receptor modulators |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070605 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 03/31/2005 | US20050070573 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 03/31/2005 | US20050070572 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 03/31/2005 | US20050070566 Imidazoquinoline derivatives |
| 03/31/2005 | US20050070508 Modulators of receptor kinases such as VEGFR; treating cancer, benign hyperplasia; 6-[2-(1-Methyl-1H-imidazol-2-yl)-thieno[3,2-b]pyridin-7-yloxy]-naphthalene-1-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for example |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/31/2005 | CA2538960A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2538591A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors |
| 03/31/2005 | CA2536439A1 Process for the synthesis of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517895A1 8-(biaryl) quinoline pde4 inhibitors |
| 03/30/2005 | EP1456213B1 Rare earth metal compounds and mixtures of these |
| 03/30/2005 | EP1444197B1 Novel phenyl-propargylether derivatives |
| 03/30/2005 | EP1194429B1 Potassium channel openers |
| 03/30/2005 | CN1602301A Process for the preparation of 4-methyl-7-aminoquinolones |
| 03/30/2005 | CN1602194A Method for treating retroviral infections |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1194969C Iridium catatlyzed enantiotropic hydrosubstituting process of aromatic pyridine ring and pyrazine ring |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872831 Reacting 3-cyanomethylthio-7-fluoro-1-methyl-4-quinolone with an acid |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/24/2005 | WO2005026165A1 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026125A1 Quinoline compounds and pharmaceutical compositions containing them |
| 03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 03/24/2005 | WO2005025507A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/24/2005 | WO2005009967A3 Quinolinone derivatives as inhibitors of c-fms kinase |
| 03/24/2005 | WO2004002956A3 Asymmetric synthesis of amino-pyrrolidinones and a crystalline, free-base amino-pyrrolidinone |
| 03/24/2005 | US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 03/24/2005 | US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission |
| 03/24/2005 | US20050065181 Using 3-(4-acetamido-3-chloroanilino)- 2-cyanopropionenic acid ester ester as chemical intermediate; acylation, alkylation, reduction, cyclization, chlorination, hydrolysis |
| 03/24/2005 | US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 03/24/2005 | US20050065163 Platelet adenosine diphosphate receptor antagonists |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | CA2538188A1 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
| 03/23/2005 | CN1599644A Method for isomerizing allyl alcohols |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1597669A 8- hydroxy quinoline bryhtening blue light and preparation method |
| 03/23/2005 | CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use |
| 03/23/2005 | CN1193989C Process for producing quinolinecarbaldehyde |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6870056 Substitituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023242A1 Entry inhibitors of the hiv virus |
| 03/17/2005 | WO2005023188A2 Compounds and methods |
| 03/17/2005 | WO2004111008A3 Use of a compound of formula i for making a pharmaceutical composition |
| 03/17/2005 | WO2004104014A3 Chiral ligands and their transition metal complexes |
| 03/17/2005 | WO2004092196A3 Tie-2 modulators and methods of use |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059678 such as (E)-N-{4-[4-(benzyloxy)-3-chloroanilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide used as antineoplastic agents, or inhibitors of the HER-2 gene or proteins and epidermal growth factor receptor enzymes |
| 03/17/2005 | US20050059650 1H-pyrazolo[3,4-d]pyrimidine derivatives as antidiabetic and antiobesity agent |
| 03/16/2005 | EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 03/16/2005 | EP1513815A1 BLUE EMITTING TRIS (8-OXOQUINOLINE) ALUMINUM (III) (AlQ3) |